Middle East & Africa Prescription Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route of Administration (Oral, Injectable, Topical, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
The Middle East & Africa (MEA) Prescription Drugs Market is projected to grow significantly, reaching an estimated US$ 64.4 billion by 2031, up from US$ 41.7 billion in 2024. This growth represents a compound annual growth rate (CAGR) of 6.4% from 2025 to 2031, driven by various factors impacting healthcare and pharmaceutical needs in the region.
Executive Summary
The rising disease burden in the MEA region is largely attributed to rapid urbanization and lifestyle changes, including unhealthy diets and sedentary habits. This has led to an increase in chronic diseases such as diabetes, cardiovascular disorders, and cancer, which in turn drives the demand for effective pharmaceutical treatments. Improvements in healthcare infrastructure and expanded healthcare coverage have made medical services more accessible, allowing a greater number of patients to receive prescriptions and necessary treatments.
Moreover, there is a growing awareness of health and wellness among the population, coupled with an increase in health insurance penetration, which encourages individuals to seek timely medical care and medication. The demographic shift, particularly the transition of a large youth population into older age groups, further supports sustained demand for prescription drugs. Government initiatives aimed at strengthening healthcare systems and promoting pharmaceutical investments are also enhancing local production and availability of medicines.
Technological advancements in medical technology and an increase in healthcare expenditure are additional factors contributing to market expansion. The influx of multinational pharmaceutical companies into the MEA region is bringing innovative drugs and improved distribution networks, thereby enhancing the accessibility of prescription medications. Collectively, these elements create a robust growth outlook for the prescription drugs market across the Middle East and Africa.
Market Segmentation Analysis
The MEA Prescription Drugs Market can be segmented based on various criteria:
The future of the MEA Prescription Drugs Market is also being shaped by advancements in personalized and precision medicine. This approach tailors healthcare based on individual genetic, environmental, and lifestyle factors, leading to more effective and targeted treatments. For instance, targeted cancer therapies like trastuzumab (Herceptin) exemplify how genetic profiling can identify patients who will benefit most from specific treatments, enhancing efficacy while minimizing adverse effects. The integration of companion diagnostics into routine clinical practice is expected to further improve drug efficacy and safety.
Technological innovations, particularly in artificial intelligence (AI) and big data analytics, are accelerating the development of personalized medicine. AI algorithms can analyze extensive datasets to predict individual drug responses, identify new therapeutic targets, and streamline drug development processes. A notable example is the partnership between MGI Tech Co., Ltd. and Prepaire Labs, which aims to advance precision medicine and drug discovery in the MEA region through the use of advanced genetic sequencing technologies.
Country Insights
The market is also analyzed by country, with significant contributions from Saudi Arabia, South Africa, and the United Arab Emirates. Saudi Arabia, in particular, held the largest market share in 2024. The Saudi pharmaceutical market was valued at approximately US$ 7.8 billion in 2021, driven by an aging population, increasing prevalence of chronic diseases, and government initiatives to enhance healthcare infrastructure under Vision 2030. The country is witnessing a rise in cancer cases, necessitating innovative treatments and long-term medication, which further propels the demand for prescription drugs.
Key Players
The MEA Prescription Drugs Market features several key players, including GSK Plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi SA, Johnson & Johnson, AstraZeneca Plc, AbbVie Inc, and Eli Lilly and Co. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.
In summary, the Middle East & Africa Prescription Drugs Market is poised for significant growth, driven by demographic changes, increasing disease prevalence, technological advancements, and strategic investments in healthcare.
Executive Summary
The rising disease burden in the MEA region is largely attributed to rapid urbanization and lifestyle changes, including unhealthy diets and sedentary habits. This has led to an increase in chronic diseases such as diabetes, cardiovascular disorders, and cancer, which in turn drives the demand for effective pharmaceutical treatments. Improvements in healthcare infrastructure and expanded healthcare coverage have made medical services more accessible, allowing a greater number of patients to receive prescriptions and necessary treatments.
Moreover, there is a growing awareness of health and wellness among the population, coupled with an increase in health insurance penetration, which encourages individuals to seek timely medical care and medication. The demographic shift, particularly the transition of a large youth population into older age groups, further supports sustained demand for prescription drugs. Government initiatives aimed at strengthening healthcare systems and promoting pharmaceutical investments are also enhancing local production and availability of medicines.
Technological advancements in medical technology and an increase in healthcare expenditure are additional factors contributing to market expansion. The influx of multinational pharmaceutical companies into the MEA region is bringing innovative drugs and improved distribution networks, thereby enhancing the accessibility of prescription medications. Collectively, these elements create a robust growth outlook for the prescription drugs market across the Middle East and Africa.
Market Segmentation Analysis
The MEA Prescription Drugs Market can be segmented based on various criteria:
- By Product Type: The market is divided into Branded and Generic drugs, with Branded drugs holding the largest market share in 2024.
- By Drug Type: It is further segmented into Small Molecule drugs and Biologics/Biosimilars, where Small Molecule drugs dominate the market.
- By Therapeutic Area: The market is categorized into Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and others, with Oncology leading in market share.
- By Route of Administration: This includes Oral, Injectable, Topical, and others, with Oral administration being the most prevalent.
- By Distribution Channel: The market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, with Hospital Pharmacies capturing the largest share.
The future of the MEA Prescription Drugs Market is also being shaped by advancements in personalized and precision medicine. This approach tailors healthcare based on individual genetic, environmental, and lifestyle factors, leading to more effective and targeted treatments. For instance, targeted cancer therapies like trastuzumab (Herceptin) exemplify how genetic profiling can identify patients who will benefit most from specific treatments, enhancing efficacy while minimizing adverse effects. The integration of companion diagnostics into routine clinical practice is expected to further improve drug efficacy and safety.
Technological innovations, particularly in artificial intelligence (AI) and big data analytics, are accelerating the development of personalized medicine. AI algorithms can analyze extensive datasets to predict individual drug responses, identify new therapeutic targets, and streamline drug development processes. A notable example is the partnership between MGI Tech Co., Ltd. and Prepaire Labs, which aims to advance precision medicine and drug discovery in the MEA region through the use of advanced genetic sequencing technologies.
Country Insights
The market is also analyzed by country, with significant contributions from Saudi Arabia, South Africa, and the United Arab Emirates. Saudi Arabia, in particular, held the largest market share in 2024. The Saudi pharmaceutical market was valued at approximately US$ 7.8 billion in 2021, driven by an aging population, increasing prevalence of chronic diseases, and government initiatives to enhance healthcare infrastructure under Vision 2030. The country is witnessing a rise in cancer cases, necessitating innovative treatments and long-term medication, which further propels the demand for prescription drugs.
Key Players
The MEA Prescription Drugs Market features several key players, including GSK Plc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG, Sanofi SA, Johnson & Johnson, AstraZeneca Plc, AbbVie Inc, and Eli Lilly and Co. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.
In summary, the Middle East & Africa Prescription Drugs Market is poised for significant growth, driven by demographic changes, increasing disease prevalence, technological advancements, and strategic investments in healthcare.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. PRESCRIPTION DRUGS MARKET LANDSCAPE
4.1 PEST Analysis
5. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. PRESCRIPTION DRUGS MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
6.2 Middle East & Africa Prescription Drugs Market Forecast and Analysis
7. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
7.1 Branded
7.1.1 Overview
7.1.2 Branded: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
7.2 Generics
7.2.1 Overview
7.2.2 Generics: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DRUG TYPE
8.1 Small Molecule
8.1.1 Overview
8.1.2 Small Molecule: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8.2 Biologics and Biosimilars
8.2.1 Overview
8.2.2 Biologics and Biosimilar: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY THERAPEUTIC AREA
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.2 Cardiovascular Diseases
9.2.1 Overview
9.2.2 Cardiovascular Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Neurological Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.4 Metabolic Diseases
9.4.1 Overview
9.4.2 Metabolic Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.5 Respiratory Diseases
9.5.1 Overview
9.5.2 Respiratory Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.7 Others
9.7.1 Overview
9.7.2 Others: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
10.1 Oral
10.1.1 Overview
10.1.2 Oral: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.2 Injectable
10.2.1 Overview
10.2.2 Injectable: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.3 Topical
10.3.1 Overview
10.3.2 Topical: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.4 Others
10.4.1 Overview
10.4.2 Others: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET - COUNTRY ANALYSIS
12.1 Middle East & Africa
12.1.1 Middle East & Africa Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.1.1 Middle East & Africa Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.2.2 Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.1.2.2.1 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Product Type
12.1.2.2.2 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Drug Type
12.1.2.2.3 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Therapeutic Area
12.1.2.2.4 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Route Of Administration
12.1.2.2.5 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Distribution Channel
12.2.3.3 South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.2.3.3.1 South Africa: Middle East & Africa Prescription Drugs Market Share - by Product Type
12.2.3.3.2 South Africa: Middle East & Africa Prescription Drugs Market Share - by Drug Type
12.2.3.3.3 South Africa: Middle East & Africa Prescription Drugs Market Share - by Therapeutic Area
12.2.3.3.4 South Africa: Middle East & Africa Prescription Drugs Market Share - by Route Of Administration
12.2.3.3.5 South Africa: Middle East & Africa Prescription Drugs Market Share - by Distribution Channel
12.3.4.4 United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.3.4.4.1 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Product Type
12.3.4.4.2 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Drug Type
12.3.4.4.3 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Therapeutic Area
12.3.4.4.4 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Route Of Administration
12.3.4.4.5 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Distribution Channel
12.4.5.5 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Product Type
12.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Drug Type
12.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Therapeutic Area
12.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Route Of Administration
12.4.5.5.5 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Distribution Channel
13 COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14 INDUSTRY LANDSCAPE
14.1 Overview
14.2 New Product Development
14.3 Merger and Acquisition
14.4 Other Strategic Developments
15 COMPANY PROFILES
15.1 GSK Plc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. Hoffmann-La Roche Ltd
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Pfizer Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Merck & Co Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Teva Pharmaceutical Industries Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Novartis AG
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Sanofi SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Johnson & Johnson
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 AstraZeneca Plc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 AbbVie Inc
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Eli Lilly and Co
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 ESTEVE
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. PRESCRIPTION DRUGS MARKET LANDSCAPE
4.1 PEST Analysis
5. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. PRESCRIPTION DRUGS MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
6.1 Middle East & Africa Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
6.2 Middle East & Africa Prescription Drugs Market Forecast and Analysis
7. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
7.1 Branded
7.1.1 Overview
7.1.2 Branded: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
7.2 Generics
7.2.1 Overview
7.2.2 Generics: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DRUG TYPE
8.1 Small Molecule
8.1.1 Overview
8.1.2 Small Molecule: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
8.2 Biologics and Biosimilars
8.2.1 Overview
8.2.2 Biologics and Biosimilar: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY THERAPEUTIC AREA
9.1 Oncology
9.1.1 Overview
9.1.2 Oncology: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.2 Cardiovascular Diseases
9.2.1 Overview
9.2.2 Cardiovascular Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.3 Neurological Diseases
9.3.1 Overview
9.3.2 Neurological Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.4 Metabolic Diseases
9.4.1 Overview
9.4.2 Metabolic Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.5 Respiratory Diseases
9.5.1 Overview
9.5.2 Respiratory Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.6 Immunology
9.6.1 Overview
9.6.2 Immunology: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
9.7 Others
9.7.1 Overview
9.7.2 Others: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY ROUTE OF ADMINISTRATION
10.1 Oral
10.1.1 Overview
10.1.2 Oral: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.2 Injectable
10.2.1 Overview
10.2.2 Injectable: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.3 Topical
10.3.1 Overview
10.3.2 Topical: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
10.4 Others
10.4.1 Overview
10.4.2 Others: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET REVENUE ANALYSIS - BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Overview
11.1.2 Hospital Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.2 Retail Pharmacies
11.2.1 Overview
11.2.2 Retail Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
11.3 Online Pharmacies
11.3.1 Overview
11.3.2 Online Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12. MIDDLE EAST & AFRICA PRESCRIPTION DRUGS MARKET - COUNTRY ANALYSIS
12.1 Middle East & Africa
12.1.1 Middle East & Africa Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.1.1 Middle East & Africa Prescription Drugs Market Revenue and Forecast and Analysis - by Country
12.1.2.2 Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.1.2.2.1 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Product Type
12.1.2.2.2 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Drug Type
12.1.2.2.3 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Therapeutic Area
12.1.2.2.4 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Route Of Administration
12.1.2.2.5 Saudi Arabia: Middle East & Africa Prescription Drugs Market Share - by Distribution Channel
12.2.3.3 South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.2.3.3.1 South Africa: Middle East & Africa Prescription Drugs Market Share - by Product Type
12.2.3.3.2 South Africa: Middle East & Africa Prescription Drugs Market Share - by Drug Type
12.2.3.3.3 South Africa: Middle East & Africa Prescription Drugs Market Share - by Therapeutic Area
12.2.3.3.4 South Africa: Middle East & Africa Prescription Drugs Market Share - by Route Of Administration
12.2.3.3.5 South Africa: Middle East & Africa Prescription Drugs Market Share - by Distribution Channel
12.3.4.4 United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.3.4.4.1 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Product Type
12.3.4.4.2 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Drug Type
12.3.4.4.3 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Therapeutic Area
12.3.4.4.4 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Route Of Administration
12.3.4.4.5 United Arab Emirates: Middle East & Africa Prescription Drugs Market Share - by Distribution Channel
12.4.5.5 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
12.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Product Type
12.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Drug Type
12.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Therapeutic Area
12.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Route Of Administration
12.4.5.5.5 Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market Share - by Distribution Channel
13 COMPETITIVE LANDSCAPE
13.1 Heat Map Analysis by Key Players
13.2 Company Positioning & Concentration
14 INDUSTRY LANDSCAPE
14.1 Overview
14.2 New Product Development
14.3 Merger and Acquisition
14.4 Other Strategic Developments
15 COMPANY PROFILES
15.1 GSK Plc
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. Hoffmann-La Roche Ltd
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Pfizer Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Merck & Co Inc
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Teva Pharmaceutical Industries Ltd
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Novartis AG
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Sanofi SA
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Johnson & Johnson
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 AstraZeneca Plc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 AbbVie Inc
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
15.11 Eli Lilly and Co
15.11.1 Key Facts
15.11.2 Business Description
15.11.3 Products and Services
15.11.4 Financial Overview
15.11.5 SWOT Analysis
15.11.6 Key Developments
15.12 ESTEVE
15.12.1 Key Facts
15.12.2 Business Description
15.12.3 Products and Services
15.12.4 Financial Overview
15.12.5 SWOT Analysis
15.12.6 Key Developments
16. APPENDIX
16.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East & Africa Prescription Drugs Market Segmentation
Table 3. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Table 4. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 5. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 6. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 7. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 8. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 9. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Country
Table 10. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 11. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 12. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 13. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 14. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 15. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 16. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 17. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 18. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 19. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 20. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 21. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 22. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 23. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 24. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 25. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 26. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 27. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 28. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 29. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 30. Heat Map Analysis by Key Players
Table 1. Middle East & Africa Prescription Drugs Market Segmentation
Table 3. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Table 4. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 5. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 6. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 7. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 8. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 9. Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Country
Table 10. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 11. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 12. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 13. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 14. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 15. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 16. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 17. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 18. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 19. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 20. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 21. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 22. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 23. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 24. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 25. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Product Type
Table 26. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Drug Type
Table 27. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Therapeutic Area
Table 28. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Route Of Administration
Table 29. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion) - by Distribution Channel
Table 30. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Middle East & Africa Prescription Drugs Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Middle East & Africa Prescription Drugs Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
Figure 7. Middle East & Africa Prescription Drugs Market Share (%) - by Product Type, 2024 and 2031
Figure 8. Branded: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 9. Generics: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 10. Middle East & Africa Prescription Drugs Market Share (%) - by Drug Type, 2024 and 2031
Figure 11. Small Molecule: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 12. Biologics and Biosimilar: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 13. Middle East & Africa Prescription Drugs Market Share (%) - by Therapeutic Area, 2024 and 2031
Figure 14. Oncology: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 15. Cardiovascular Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 16. Neurological Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 17. Metabolic Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 18. Respiratory Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 19. Immunology: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 20. Others: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 21. Middle East & Africa Prescription Drugs Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Oral: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 23. Injectable: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 24. Topical: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 25. Others: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 26. Middle East & Africa Prescription Drugs Market Share (%) - by Distribution Channel, 2024 and 2031
Figure 27. Hospital Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 28. Retail Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 29. Online Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 30. Middle East & Africa Prescription Drugs Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 31. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 32. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 33. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 34. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 35. Company Positioning & Concentration
Figure 1. Middle East & Africa Prescription Drugs Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Middle East & Africa Prescription Drugs Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Prescription Drugs Market Revenue (US$ Billion), 2024 - 2031
Figure 7. Middle East & Africa Prescription Drugs Market Share (%) - by Product Type, 2024 and 2031
Figure 8. Branded: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 9. Generics: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 10. Middle East & Africa Prescription Drugs Market Share (%) - by Drug Type, 2024 and 2031
Figure 11. Small Molecule: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 12. Biologics and Biosimilar: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 13. Middle East & Africa Prescription Drugs Market Share (%) - by Therapeutic Area, 2024 and 2031
Figure 14. Oncology: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 15. Cardiovascular Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 16. Neurological Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 17. Metabolic Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 18. Respiratory Diseases: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 19. Immunology: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 20. Others: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 21. Middle East & Africa Prescription Drugs Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Oral: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 23. Injectable: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 24. Topical: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 25. Others: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 26. Middle East & Africa Prescription Drugs Market Share (%) - by Distribution Channel, 2024 and 2031
Figure 27. Hospital Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 28. Retail Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 29. Online Pharmacies: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 30. Middle East & Africa Prescription Drugs Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 31. Saudi Arabia: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 32. South Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 33. United Arab Emirates: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 34. Rest of Middle East & Africa: Middle East & Africa Prescription Drugs Market - Revenue and Forecast, 2021 - 2031 (US$ Billion)
Figure 35. Company Positioning & Concentration
